Clinical Trial Update: Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing a methadone-based strategy for infants with neonatal abstinence syndrome; the study was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome

Drugs mentioned

• Methadone (methadone)

Snippet

Sponsor: Johns Hopkins All Children's Hospital | Conditions: Neonatal Abstinence Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2020-05-19